Monopar Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.40
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
1
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.22
|
-0.19
|
0.03
|
13.64%
|
|
2022-06-30
|
-0.21
|
-0.22
|
-0.01
|
-4.76%
|
|
2022-03-31
|
-0.22
|
-0.19
|
0.03
|
13.64%
|
|
2021-12-31
|
-0.19
|
-0.21
|
-0.02
|
-10.53%
|
|
2021-09-30
|
-0.21
|
-0.20
|
0.01
|
4.76%
|
|
2021-06-30
|
-0.19
|
-0.17
|
0.02
|
10.53%
|
|
2021-03-31
|
-0.19
|
-0.16
|
0.03
|
15.79%
|
|
2020-12-31
|
-0.19
|
-0.20
|
-0.01
|
-5.26%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.60
|
|
2021-12-31
|
-0.74
|
|
2020-12-31
|
-0.59
|
|
2019-12-31
|
-0.38
|
|
2018-12-31
|
-0.17
|